Anomaly Bio is a Singapore-based company developing next-generation inputs through advanced fermentation and strain engineering. Anomaly engineers microbes to convert readily available feedstocks, such as sugars, into high-value molecules for applications in crop protection, nutrition, and personal care.

By transforming microbes into efficient cell factories, Anomaly aims to replace fragile supply chains with scalable, on-demand, and globally viable biomanufacturing that redefines how essential ingredients are made.